Ethics & Protocol ⏱️ 5 min read

The Clinical Study Protocol & Informed Consent Architecture

The ethical and operational foundation governing all clinical trials, subject eligibility, and data collection.

Made2Stick
Made2Stick Editorial Team Reviewed by Senior Clinical Research & CDISC Faculty

📌 Direct Answer / Executive Definition

The Clinical Study Protocol is the comprehensive master plan approved by Institutional Review Boards (IRB/IEC) that defines the study objectives, inclusion/exclusion criteria, dosing regimens, visit schedules, and endpoint measurements. Informed Consent is the legally mandated process ensuring subjects voluntarily agree to participate after receiving transparent disclosure of trial risks and benefits.

🎬 Classroom Video Blueprint: The Clinical Study Protocol & Informed Consent Architecture
Masterclass Frame
The Clinical Study Protocol & Informed Consent Architecture Video Slide ▶ Watch in Video Player →

Why Protocol Integrity & Informed Consent Mandates Matter in Clinical Trials

Every SAS dataset, SDTM domain, and protocol deviation check originates from the rules explicitly defined in the study protocol and consent documentation.

Standard Syntax, Derivation & Framework Pattern

/* Checking Subject Eligibility & Inclusion Criteria */
DATA work.eligibility_check;
    SET raw.ie;
    WHERE IECAT = 'INCLUSION';
    IF IETESTCD = 'AGE' AND (IEORRES_NUM < 18 OR IEORRES_NUM > 75) THEN 
        Protocol_Violation = 'Y';
    ELSE Protocol_Violation = 'N';
RUN;

Core Rules & Certification Takeaways

  • The Clinical Study Protocol must be approved by an Institutional Review Board (IRB) or Ethics Committee before patient enrollment.
  • Inclusion/Exclusion criteria define the exact patient population eligible for trial randomization.
  • Informed consent must be obtained and signed *before* any study-related procedure or treatment is performed.
  • Protocol amendments trigger updates to eCRF database specifications and downstream SDTM mapping rules.

🔗 Related Architectural Concepts & Next Steps

Deepen your mastery with connected topics across our curriculum and knowledge hubs.

Regulatory Blueprint Clinical
Statistical Analysis Plan (SAP) & Mock Shells Read Guide →
Drug Development Clinical
Phases I to IV Overview Read Guide →
Governance & Risk Project
Project Charters & Governance Read Guide →

Frequently Asked Questions (FAQ)

Who approves the Clinical Study Protocol before a trial starts?

The protocol must be reviewed and approved by the regulatory health authorities (such as the FDA/EMA) and an independent Institutional Review Board (IRB) or Ethics Committee.

Can a subject withdraw informed consent during a trial?

Yes. Informed consent is voluntary, and participants can withdraw from the clinical trial at any time without penalty or loss of medical care.

Want complete video breakdowns & exercises?

Explore full step-by-step masterclass training in Clinical SAS Programming & Clinical Trials.

Enroll in Clinical SAS Masterclass →
← Back to Clinical SAS & CDISC Knowledge Hub Overview